Symetryx Corp - Insider Non-Derivative Transactions at NeuBase Therapeutics, Inc. (NBSE) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Sep 18, 2023, Symetryx Corp's relationship to NeuBase Therapeutics, Inc. (NBSE) is TenPercentOwner, and currently has 0 shares of Common Stock, Par Value $0.0001 per Share.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other NBSE insiders.

Data Source: SEC.
Symetryx Corp - Insider Non-Derivative Transactions of NBSE Common Stock, Par Value $0.0001 per Share
Symetryx Corp - Insider Non-Derivative Transactions at NBSE
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Sep 19, 2023 Sell -- (Common Stock, Par Value $0.0001 per Share) 50000 1.19 0
Sep 16, 2023 Sell -- (Common Stock, Par Value $0.0001 per Share) 103337 1.26 50000
Sep 15, 2023 Sell -- (Common Stock, Par Value $0.0001 per Share) 129108 1.44 153337
Sep 12, 2023 Sell -- (Common Stock, Par Value $0.0001 per Share) 3376 1.44 472926
Sep 9, 2023 Sell -- (Common Stock, Par Value $0.0001 per Share) 128847 1.53 476302
Sep 8, 2023 Sell -- (Common Stock, Par Value $0.0001 per Share) 74852 1.8 605149
Sep 2, 2023 P -- (Common Stock, Par Value $0.0001 per Share) 61076 0.98 680081